The use of a thromboelastometry-based algorithm reduces the need for blood product transfusion during orthotopic liver transplantation A randomised controlled study

被引:45
|
作者
Bonnet, Aurelie [1 ]
Gilquin, Nathalie [1 ]
Steer, Nadia [1 ]
Gazon, Mathieu [1 ]
Quattrone, Diego [1 ]
Pradat, Pierre [3 ]
Maynard, Marianne [3 ]
Mabrut, Jean-Yves [2 ]
Aubrun, Frederic [1 ]
机构
[1] Dept Anesthesie & Reanimat, Lyon, France
[2] Dept Chirurg Hepatobiliaire & Transplantat Hepat, Lyon, France
[3] Hosp Civils Lyon, Grp Hosp Nord, Ctr Rech Clin, Lyon, France
关键词
CONVENTIONAL COAGULATION TESTS; ACUTE LUNG INJURY; ROTATIONAL THROMBOELASTOMETRY; FIBRINOGEN; DISEASE; PLASMA; THROMBELASTOGRAPHY; HYPERFIBRINOLYSIS; REQUIREMENTS; COAGULOPATHY;
D O I
10.1097/EJA.0000000000001084
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND Orthotopic liver transplantation is associated with a risk of bleeding. Coagulation in cirrhotic patients is difficult to assess with standard coagulation tests because of rebalanced coagulation. This can be better assessed by thromboelastometry which can detect coagulation impairments more specifically in such patients. OBJECTIVES Our first objective was to compare the number of units of blood products transfused during liver transplantation when using an algorithm based on standard coagulation tests or a thromboelastometry-guided transfusion algorithm. DESIGN Randomised controlled trial. SETTING Single-centre tertiary care hospital in France, from December 2014 to August 2016. PARTICIPANTS A total of 81 adult patients undergoing orthotopic liver transplantation were studied. Patients were excluded if they had congenital coagulopathies. INTERVENTION Transfusion management during liver transplantation was guided either by a standard coagulation test algorithm or by a thromboelastometry-guided algorithm. Transfusion, treatments and postoperative outcomes were compared between groups. MAIN OUTCOME MEASURES Total number of transfused blood product units during the operative period (1 U is one pack of red blood cells (RBCs), fresh frozen plasma (FFP) or platelets). RESULTS Median [interquartile range] intra-operative transfusion requirement was reduced in the thromboelastometry group (3 [2 to 4] vs. 7 [4 to 10] U, P = 0.005). FFP and tranexamic acid were administered less frequently in the thromboelastometry group (respectively 15 vs. 46.3%, P = 0.002 and 27.5 vs. 58.5%, P = 0.005), whereas fibrinogen was more often infused in the thromboelastometry group (72.5 vs. 29.3%, P < 0.001). Median transfusions of FFP (3 [2 to 6] vs. 4 [2 to 7] U, P = 0.448), RBCs (3 [2 to 5] vs. 4 [2 to 6] U, P = 0.330) and platelets (1 [1 to 2] vs. 1 [1 to 2] U, P = 0.910) were not different between groups. In the postoperative period, RBC or platelet transfusion, the need for revision surgery or occurrence of haemorrhage were not different between groups. CONCLUSION A transfusion algorithm based on thromboelastometry assessment of coagulation reduced the total number of blood product units transfused during liver transplantation, particularly FFP administration.
引用
收藏
页码:825 / 833
页数:9
相关论文
共 50 条
  • [21] TRENDS IN BLOOD AND BLOOD PRODUCT USE DURING INTRAOPERATIVE ORTHOTOPIC LIVER TRANSPLANTATION IN SOUTH AUSTRALIA'S LIVER TRANSPLANT CENTRE
    Gore, Cathie
    John, Libby
    Spooner, Michaela
    Sinha, Romi
    INTERNAL MEDICINE JOURNAL, 2021, 51
  • [22] Impact of Rotational Thromboelastometry on Blood Use and Patient Outcome in High-Risk Orthotopic Liver Transplantation
    Chang, S.
    Kwok, W. A.
    Ward, D. C.
    Ziman, A.
    McGonigle, A. M.
    TRANSFUSION, 2016, 56 : 106A - 106A
  • [23] Reply:: Reduction of blood product transfusion requirements during liver transplantation
    Massicotte, Luc
    Lenis, Serge
    Thibeault, Lynda
    Sassine, Marie-Pascale
    Seal, Robert F.
    Roy, Andre
    LIVER TRANSPLANTATION, 2006, 12 (08) : 1306 - 1306
  • [24] Thromboelastography-Based Transfusion Algorithm Reduces Blood Product Use after Elective CABG: A Prospective Randomized Study
    Ak, Koray
    Isbir, Cemil S.
    Tetik, Sermin
    Atalan, Nazan
    Tekeli, Atike
    Aljodi, Maher
    Civelek, Ali
    Arsan, Sinan
    JOURNAL OF CARDIAC SURGERY, 2009, 24 (04) : 404 - 410
  • [25] Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: A prospective, randomized, double-blind study
    Findlay, JY
    Rettke, SR
    Ereth, MH
    Plevak, DJ
    Krom, RAF
    Kufner, RP
    LIVER TRANSPLANTATION, 2001, 7 (09) : 802 - 807
  • [26] THE EFFECT OF APROTININ ON BLOOD PRODUCT REQUIREMENTS DURING ORTHOTOPIC LIVER-TRANSPLANTATION
    BECHSTEIN, WO
    RIESS, H
    NEUHAUS, P
    HIMMELREICH, G
    STEFFEN, R
    SLAMA, KJ
    ROSSAINT, R
    BLUMHARDT, G
    CLINICAL TRANSPLANTATION, 1991, 5 (06) : 422 - 426
  • [27] APROTININ REDUCES THE NEED FOR BLOOD PRODUCTS DURING LIVER-TRANSPLANTATION
    SCUDAMORE, CH
    RANDALL, TE
    JEWESSON, PJ
    SHACKLETON, CR
    SALVIAN, AJ
    FAGAN, M
    FRIGHETTO, L
    GROWE, GH
    SCARTH, I
    ERB, SR
    AMERICAN JOURNAL OF SURGERY, 1995, 169 (05): : 546 - 549
  • [28] Effects of Vasoactive Agents on Blood Loss and Transfusion Requirements during Orthotopic Liver Transplantation
    Vitin, Alexander A.
    Martay, Kenneth
    Vater, Youri L.
    Dembo, Gregory A.
    LIVER TRANSPLANTATION, 2014, 20 : S130 - S130
  • [29] Aprotinin significantly reduces red blood cell transfusion requirements in patients undergoing orthotopic liver transplantation
    Kufner, RP
    Ereth, MH
    Krom, RAF
    Findlay, JY
    Rettke, SR
    ANESTHESIOLOGY, 1998, 89 (3A) : U270 - U270
  • [30] Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study
    Porte, RJ
    Molenaar, IQ
    Begliomini, B
    Groenland, THN
    Januszkiewicz, A
    Lindgren, L
    Palareti, G
    Hermans, J
    Terpstra, OT
    LANCET, 2000, 355 (9212): : 1303 - 1309